Sargramostim for sulfasalazine-induced agranulocytosis.
Rospond
R M
RM
Glowacki
R C
RC
Mailliard
J A
JA
D000293:Adolescent; D000380:Agranulocytosis / Q000139:chemically induced / Q000188:drug therapy*; D003875:Drug Eruptions / Q000209:etiology; D005334:Fever / Q000139:chemically induced; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011537:Pruritus / Q000139:chemically induced; D011994:Recombinant Proteins / Q000627:therapeutic use; D012460:Sulfasalazine / Q000009:adverse effects*
D011994:Recombinant Proteins; D012460:Sulfasalazine; C081222:sargramostim; D016178:Granulocyte-Macrophage Colony-Stimulating Factor